Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab. | LitMetric

A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab. | LitMetric

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib-rituximab.

Blood Cancer J

Biothecnology Research Unit, AO of Cosenza, Cosenza, Italy.

Published: September 2020

Download full-text PDF
Source

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494850 PMC
http://dx.doi.org/10.1038/s41408-020-00358-3 DOI Listing

Publication Analysis

Top Keywords

validation survival-risk

4

survival-risk score

4

score srs

4

srs relapsed/refractory

4

relapsed/refractory cll

4

cll patients

4

patients treated

4

treated idelalisib-rituximab

4

validation

1

score

1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!